公司資料
Forte Biosciences 股價、新聞與催化劑
- 股票代碼:
- FBRX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
76.95 USD (+0.04%)
收盤價
最後更新: 2026年8月24日
372M USD
市值
股價為何變動
As of Aug 24, 2026, FBRX was little changed and closed at $76.95. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Forte Biosciences is a clinical-stage biotechnology company focused on dermatology and immune-mediated disease. Its profile is built around translating immune and skin biology into differentiated therapies.
所在地與產業分類
Forte is headquartered in the United States and listed on NASDAQ. It sits in specialty biotech with a dermatology and immunology focus.
商業模式特徵
The company depends on clinical progress, dose selection, and pipeline prioritization to create value. Investors usually watch proof-of-concept data and whether the company can build a differentiated immune-dermatology franchise.
生技產業定位
Forte occupies a small but catalyst-sensitive dermatology niche within biotech. The stock is typically driven by clinical updates and the market's view of the platform's differentiation.
未來催化劑
- Forte Biosciences’ catalysts are FB-102 and any dermatology / immune-disease update that shows the program still has a strong path. The market will care about whether the next data point supports the platform thesis.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。